Parkinsons DiseaseDANCE-PDNCT01163344
Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
An observational study of Parkinsons Disease, run by Beth Israel Deaconess Medical Center at 1 site in United States.
Trial summary
The purpose of this study is to gather data to see if so-called enriched forms of exercise programs such as dance is more effective in improving balance and quality of life in patients with idiopathic Parkinson's disease than regular exercise programs that are currently provided by physical therapists. Read more about this study
- Who is it for?
- Ages 40 to 79 years
- Conditions the study is for
- Parkinsons Disease
- How many people
- 31 participants
- Where
- 1 siteUnited States
- Study dates
- Jul 2010to Dec 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 79 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: To qualify for this study, subject must have been diagnosed with Parkinson's Disease for 3 years or more, be less than 80 years of age, and have problems with gait and balance
Who may be able to join
- Diagnosis of PD at least 3 years ago
- Less than 80 years of age
- Have gait and balance issues
Who cannot join
- Diagnosis of PD for less than 3 years
- 80 years of age or older
- Not have gait and balance issues
Trial locations and contacts
1 site in 1 country.
United States1 site
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
About this study
The purpose of this study is to gather data to see if so-called enriched forms of exercise programs such as dance is more effective in improving balance and quality of life in patients with idiopathic Parkinson's disease than regular exercise programs that are currently provided by physical therapists.
Read the detailed description
Comparison of traditional PT to dance in people who have parkinsons disease to measure which is better for gait, balance and QOL.
- Conditions
- Parkinsons Disease
- Keywords
- Gait, balance, Parkinson's Disease
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Dance Therapy Group | This will group will undergo dance therapy once a week for a series of 8 weeks. | |
| Physical Therapy Group | This group will undergo physical therapy sessions once a week for a series of 8 weeks |
What is being measured
The primary outcome is the main question the study is designed to answer.
Balance and Gait improvement
We seek to determine if balance and gait are improved as a result of dance therapy. This will be compared to the balance and gait data of group physical therapy.
Measured: 10 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jul 2010 (estimated)
- Study startJul 2010
- Primary completionDec 2015
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinsons DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Daniel Tarsy, Beth Israel Deaconess Medical Center
- Investigators
- Daniel Tarsy, MD, Principal investigator, Beth Israel Deaconess Medical CenterVeronique Vanderhorst, MD, PhD, Principal investigator, Beth Israel Deaconess Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01163344
- Sponsor's protocol ID
- 2010P000029
- Acronym
- DANCE-PD
- Status last verified
- Mar 2017
- First submitted
- 14 Jul 2010
- Last updated
- 16 Mar 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Mar 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
- ClinicalTrials.gov ID
- NCT01163344
- Acronym / sponsor ID
- DANCE-PD / 2010P000029
- Conditions
- Parkinsons Disease
- Keywords
- Gait, balance, Parkinson's Disease
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- Beth Israel Deaconess Medical CenterUniversity, hospital or other
- Study start
- Jul 2010
- Primary completion
- Dec 2015 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 15 Jul 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to gather data to see if so-called enriched forms of exercise programs such as dance is more effective in improving balance and quality of life in patients with idiopathic Parkinson's disease than regular exercise programs that are currently provided by physical therapists.
Detailed description
Comparison of traditional PT to dance in people who have parkinsons disease to measure which is better for gait, balance and QOL.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Dance Therapy Group | – | –This will group will undergo dance therapy once a week for a series of 8 weeks. |
| Physical Therapy Group | – | –This group will undergo physical therapy sessions once a week for a series of 8 weeks |
Who may qualify
- Ages
- 40 to 79 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- To qualify for this study, subject must have been diagnosed with Parkinson's Disease for 3 years or more, be less than 80 years of age, and have problems with gait and balance
Key inclusion criteria (3 listed)
- Diagnosis of PD at least 3 years ago
- Less than 80 years of age
- Have gait and balance issues
Key exclusion criteria (3 listed)
- Diagnosis of PD for less than 3 years
- 80 years of age or older
- Not have gait and balance issues
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Balance and Gait improvement
Time frame: 10 weeks
We seek to determine if balance and gait are improved as a result of dance therapy. This will be compared to the balance and gait data of group physical therapy.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Mar 2017.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Parkinsons Disease
RecruitingObservational study
Evaluation and Treatment of Neurosurgical Disorders
Neurologic Disorders
Enrolling by invitation
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease
Parkinson's Disease, Depression
Not yet recruitingPhase 2
Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)
PARKINSON DISEASE (Disorder)
RecruitingObservational study
PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's
Parkinson Disease
Recruiting
Non-invasive Brain Stimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
Parkinson Disease, Mild Cognitive Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Daniel Tarsy, MD principal investigator
Beth Israel Deaconess Medical Center
Veronique Vanderhorst, MD, PhD principal investigator
Beth Israel Deaconess Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Parkinsons Disease, run by Beth Israel Deaconess Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Balance and Gait improvement (time frame: 10 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2017.